pegylated TOP1 inhibitor PEEL-224
Term · Oncology and biomedicine · MLC-T-ONC-015933
A pegylated camptothecin derivative, with potential antineoplastic activity. Upon administration of pegylated TOP1 inhibitor PEEL-224, camptothecin reaches the tumor cells and selectively stabilizes covalent topoisomerase I-DNA complexes, which results in single-stranded and double-stranded DNA breaks, the inhibition of DNA replication, and the induction of apoptosis. Pegylation allows for increases in half-life and the exposure time for tumor cells, while decreasing both blood plasma concentrations and exposure to off-target organs. This may increase efficacy and reduce systemic toxicities.
| Identifier | MLC-T-ONC-015933 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | topoisomerase-I inhibitor PEEL-224 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015933",
"term": "pegylated TOP1 inhibitor PEEL-224",
"field": "Oncology and biomedicine",
"definition": "A pegylated camptothecin derivative, with potential antineoplastic activity. Upon administration of pegylated TOP1 inhibitor PEEL-224, camptothecin reaches the tumor cells and selectively stabilizes covalent topoisomerase I-DNA complexes, which results in single-stranded and double-stranded DNA breaks, the inhibition of DNA replication, and the induction of apoptosis. Pegylation allows for increases in half-life and the exposure time for tumor cells, while decreasing both blood plasma concentrations and exposure to off-target organs. This may increase efficacy and reduce systemic toxicities.",
"synonyms": [
"topoisomerase-I inhibitor PEEL-224"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pegylated-top1-inhibitor-peel-224/"
}
Record 12,878 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.